For the first time in decades, the US Food and Drug Administration has signed off on new antibiotics to fight gonorrhea. The ...

Thursday, the FDA addressed the shortfall with a label expansion for GSK’s Blujepa, which brings an oral option and a new ...

On Friday, the F.D.A. approved a new antibiotic, zoliflodacin, a day after an article published in The Lancet reported that a ...

The drug is from a new class of antibiotics, the first new class in decades to be approved as a treatment for gonorrhea, ...

The U.S. health regulator on Friday approved Innoviva's oral antibiotic to treat gonorrhea, a common sexually transmitted ...

The real-world study adds to previous randomized controlled trial findings suggesting that shorter courses of antibiotic therapy can be sufficient for hospitalized patients with mild or moderate ...

Please provide your email address to receive an email when new articles are posted on . A recent study suggests that incomplete antibiotic therapy should be avoided and that transition to oral ...

A powerful new antibiotic candidate has been hiding in plain sight inside a well known bacterial compound, and in early lab ...

AbbVie's combination antibiotic Emblaveo has gotten federal approval to treat complicated intra-abdominal infections, making it the first and only such therapy approved to fight antimicrobial ...

In our current health care environment, hospitals and health care providers are challenged to provide a high standard of care in a more efficient way. Multiple evidence-based practice guidelines ...

New Lyme borreliosis guidelines outline the full spectrum of clinical manifestations, from erythema migrans to ...

In a recent study published in The Lancet’s eClinical Medicine, researchers performed a meta-analysis of randomized controlled trials (RCTs) to evaluate the safety of short-course antibiotic treatment ...